ELOVL2 and neuroblastoma: Given the known metabolic reprogramming in castration-resistant progression and the context-dependent roles of ELOVL2 across cancers (oncogenic in renal carcinoma vs. tumor-suppressive in neuroblastoma), we hypothesized that ELOVL2 may exhibit stage-specific functional plasticity in PCa.